Merck & Co. Inc. for years hid clinical evidence that showed Vioxx posed a heart attack risk, the lawyer for the plaintiff told a jury on Wednesday in the first civil trial against the drugmaker’s popular painkiller.
*For more on this story,
read the full Reuters article.